In recent years, a discernable shift has taken place in the development of cancer therapeutics, marked by a growing emphasis on innovative drug delivery strategies. The focus has been on tailoring these strategies to enhance the precision of therapeutic targeting to tumor sites. Despite the undeniable success of conventional cancer treatment methods, they have several …
